Incidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates

Simple item page
dc.creatorAl Hosani, H.
dc.creatorSalah, M.
dc.creatorOsman, H.M.
dc.creatorFarag, H.M.
dc.creatorAnvery, S.M.
dc.date2014-06-17T07:27:29Z
dc.date2014-06-17T07:27:29Z
dc.date2005-12-31
dc.date.accessioned2026-08-03T10:12:30Z
dc.description300-307
dc.descriptionIn January 2002, a pilot programme of neonatal screening for sickle cell disease was launched in the United Arab Emirates [UAE] in 3 districts of Abu Dhabi emirate. This paper reports the incidence of sickle cell diseases, other haemoglobinopathies and haemoglobinopathy carriers over a 12-month period using high performance liquid chromatography as a primary screening method. The overall incidence of sickle cell disease among 22 200 screened neonates was 0.04% [0.07% for UAE citizens and 0.02% for non-UAE citizens]. The incidence of sickle cell trait was 1.1% overall [1.5% for UAE citizens and 0.8% for non-UAE citizens]. Universal neonatal screening for sickle cell haemoglobin at the national level should be considered
dc.formatapplication/pdf
dc.identifier1020-3397
dc.identifierhttp://applications.emro.who.int/emhj/1103/11_3_2005_300_307.pdf
dc.identifierhttps://iris.who.int/handle/10665/116946
dc.identifier.urihttps://repo.dare.co.zw/handle/123456789/236723
dc.languageEnglish
dc.languageen
dc.relationEMHJ - Eastern Mediterranean Health Journal, 11 (3), 300-307, 2005
dc.subjectBirth Rate
dc.subjectChromatography, Liquid
dc.subjectFollow-Up Studies
dc.subjectGenetic Counseling
dc.subjectHemoglobin C Disease
dc.subjectAnemia, Sickle Cell
dc.titleIncidence of haemoglobinopathies detected through neonatal screening in the United Arab Emirates

Files

Collections

WHO IRIS